Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Exec VP Conafay resigns; committee of three company reps will guide lobbying effort in interim.

Executive Summary

PhRMA CAPITOL HILL EFFORT WILL BE OVERSEEN BY THREE COMPANY EXECS from the government affairs offices of member companies following the Dec. 13 resignation by association Exec VP Stephen Conafay. The heads of the D.C. offices of Warner-Lambert (Vincent LoVoi) and Bristol-Myers Squibb (Richard Thompson) and the director of public policy at Lilly in Indianapolis (Anne Nobles) have been assigned to maintain the association's lobbying efforts. The three representatives were chosen because they are the top federal government relations staff for the current chairman of the association (Warner-Lambert's Lodewijk de Vink), the upcoming chairman (BMS Chairman Charles Heimbold), and the treasurer and chairman for 1997-1998 (Lilly Exec VP Sidney Taurel).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel